Enlace del recurso
Enlace del recurso
Enlace del recurso

“…PURPOSE: This study investigated the impact of changing availability of tamper‐deterrent and non‐tamper‐deterrent oxycodone on prescribing patterns of controlled‐release oxycodone across Canada. METHODS: We conducted a population‐based, serial cross‐sectional study of controlled‐release oxycodone dispensing from community pharmacies across Canada between October 2007 and April 2016. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This population-based cohort study assesses the prevalence of opioid use in pregnant women in Ontario, Canada, from 2014 through 2019.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We describe the epidemiology of benzodiazepine-related toxicity in Ontario, Canada. METHODS: We conducted a population-based, cross-sectional study of Ontario residents who had an emergency department visit or hospitalization for benzodiazepine-related toxicity between January 1, 2013 and December 31, 2020. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: We conducted a population-based, serial, cross-sectional study of prescriptions dispensed from pharmacies in the 3 cities with the highest volume of US–Canada border crossings in Ontario: Niagara Falls, Windsor and Sarnia. …”
Enlace del recurso
Enlace del recurso

“…This cross-sectional study quantifies the added burden of fatal opioid overdoses during the first 6 months of the COVID-19 pandemic in Ontario, Canada.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…We conducted a population-based, repeated cross-sectional time-series study among very high-dose (≥200 MME) opioid recipients in Ontario, Canada, to examine changes in the monthly prevalence of rapid tapering from 2014 to 2018, defined as recipients experiencing either a ≥50% reduction in daily doses or abrupt discontinuation sustained for 30 days. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…This study’s objective was to examine interprovincial variation in outpatient antibiotic dispensing in Canada in 2019. METHODS: We conducted a cross-sectional study of antibiotic prescriptions dispensed in Canadian provinces in 2019, leveraging the IQVIA Geographic Prescription Monitor database. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Access to direct-acting antivirals (DAAs) in Canada increased following several policy changes, however the real-world impact of expanded DAA access and increased use of these drugs is unknown. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…OBJECTIVE: To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional analysis of rates of OAT and opioid-related deaths between 2013 and 2021 used data obtained from the Ontario Drug Policy Research Network, Public Health Ontario, and Statistics Canada. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

Enlace del recurso
Enlace del recurso
Enlace del recurso

“…DESIGN: Population based cohort study. SETTING: Ontario, Canada, from 1 January 2013 to 31 December 2016. PARTICIPANTS: All Ontarians who died of an opioid related cause. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS AND FINDINGS: We conducted a retrospective cohort study using linked administrative data among residents of Ontario, Canada whose enrolment with a physician practicing in a primary care enrolment model (PEM) was terminated between January 2016 and December 2017. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND AND AIMS: In June 2016, the Ontario, Canada government implemented the Ontario Naloxone Program for Pharmacies (ONPP), authorizing pharmacists to provide injectable naloxone kits at no charge to all Ontario residents. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The current development of potential national pharmacare strategies in Canada must optimize the use of high-cost drugs to ensure the sustainability of the program.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: Low-dose codeine products can be purchased without a prescription in most of Canada. We explored trends in the purchasing of these products across the Canadian provinces from 2014 to 2019, evaluating the impact of Health Canada’s 2016 announcement of a proposed regulatory change and the 2017 opening of a 60-day public comment period, as well as the impact of Manitoba’s 2016 policy change requiring a prescription for the purchase of all codeine products in that province. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso